BIRMINGHAM, Ala., Feb. 18 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc.

BIRMINGHAM, Ala., Feb. 4 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc.

BIRMINGHAM, Ala., Feb. 1 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that Jon P.

BIRMINGHAM, Ala., Jan. 26 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that its partner, Shionogi & Co., Ltd. will launch RAPIACTA, intravenous (i.v.) peramivir anti-viral, to treat patients with influenza in Japan, on January 27, 2010.

BIRMINGHAM, Ala., Jan. 21 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals (Nasdaq: BCRX) today announced that its fourth quarter 2009 financial results will be released on Thursday, February 4, 2010. BioCryst will host a conference call and Web cast at 11:00 a.m.